COSENTYX
Live / Registered — Registered and renewed (as of 01 Apr 2025)
What this means for you
Registered since 07 Apr 2015. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 07 Apr 2025).
Record
- Serial number
- 85804029
- Registration number
- 4716891
- Mark type
- Stylized text
- Filed
- 17 Dec 2012
- Published for opposition
- 14 May 2013
- Registered
- 07 Apr 2015
- Next maintenance due
- 07 Apr 2025
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Anti-inflammatories; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for use in dermatology
Owner
- Novartis AG, Basel, CH
- Novartis AG, Basel, CH
- Novartis AG, Basel, CH
Prior registrations
Prosecution history
- 01 Apr 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 01 Apr 2025 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 01 Apr 2025 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 01 Apr 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 14 Nov 2024 — TEAS SECTION 8 & 9 RECEIVED
- 07 Apr 2024 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 09 Apr 2021 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 09 Apr 2021 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 01 Feb 2021 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 20 Oct 2020 — TEAS SECTION 8 & 15 RECEIVED
- 07 Apr 2020 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 07 Apr 2015 — REGISTERED-PRINCIPAL REGISTER
- 06 Mar 2015 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 05 Mar 2015 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 14 Feb 2015 — STATEMENT OF USE PROCESSING COMPLETE